Leonteq Securities AG’s Hims & Hers Health HIMS Stock Holding History

Leonteq Securities AG’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$123K	Sell	3,539 -5,307	-60%	-$142K	﹤0.01%	658
2026 Q1	$184K	Buy	8,846 +1,818	+26%	+$42.9K	0.01%	618
2025 Q4	$228K	Buy	7,028 +4,054	+136%	+$174K	0.01%	636
2025 Q3	$169K	Sell	2,974 -620	-17%	-$31.8K	0.01%	629
2025 Q2	$179K	Sell	3,594 -1,864	-34%	-$84.2K	0.01%	599
2025 Q1	$161K	Buy	5,458 +3,457	+173%	+$128K	0.01%	594
2024 Q4	$48.4K	Sell	2,001 -3,226	-62%	-$79.9K	﹤0.01%	827
2024 Q3	$96.3K	Buy	5,227 +95	+2%	+$1.7K	0.01%	630
2024 Q2	$104K	Buy	5,132 +132	+3%	+$2.2K	0.01%	618
2024 Q1	$77.3K	Sell	5,000 -130	-3%	-$1.47K	0.01%	693
2023 Q4	$45.7K	Hold	5,130	–	–	﹤0.01%	811
2023 Q3	$32.3K	Hold	5,130	–	–	﹤0.01%	875
2023 Q2	$48.2K	Hold	5,130	–	–	﹤0.01%	834
2023 Q1	$50.9K	Sell	5,130 -9,170	-64%	-$80.4K	﹤0.01%	794
2022 Q4	$91.7K	Buy	14,300 +300	+2%	+$1.71K	﹤0.01%	685
2022 Q3	$78.1K	Hold	14,000	–	–	﹤0.01%	698
2022 Q2	$63.4K	Buy	14,000 +8,000	+133%	+$34.1K	﹤0.01%	775
2022 Q1	$32K	Buy	+6,000	New	+$29.7K	﹤0.01%	944

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Leonteq Securities AG's HIMS Position: Q2 2026 in Review

Leonteq Securities AG reduced its Hims & Hers Health (HIMS) stake by 60% in Q2 2026, selling an estimated $142K and leaving 3,539 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #658.

Leonteq Securities AG first reported a position in HIMS in Q1 2022 and has held it in 18 quarters since. The position peaked at $228K in Q4 2025. 503 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Leonteq Securities AG held 3,539 shares of Hims & Hers Health worth $123K as of Q2 2026.
Leonteq Securities AG sold 5,307 Hims & Hers Health shares in Q2 2026, an estimated $142K.
Hims & Hers Health made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #658 holding.
Leonteq Securities AG first reported a position in Hims & Hers Health in Q1 2022 and has held it in 18 quarters since.
Leonteq Securities AG's Hims & Hers Health position peaked at $228K in Q4 2025.
503 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.